VANGUARD GROUP INC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 219 filers reported holding NPS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$213,371,000
+39.2%
5,965,074
+1.2%
0.02%
+25.0%
Q3 2014$153,280,000
-21.1%
5,895,377
+0.4%
0.01%
-20.0%
Q2 2014$194,159,000
+13.9%
5,874,715
+3.2%
0.02%
+7.1%
Q1 2014$170,402,000
+0.3%
5,693,314
+1.7%
0.01%
-6.7%
Q4 2013$169,960,000
-2.2%
5,598,146
+2.5%
0.02%
-11.8%
Q3 2013$173,738,000
+114.5%
5,461,757
+1.8%
0.02%
+88.9%
Q2 2013$81,004,0005,364,4260.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders